CN105456699A - 一种治疗疲劳综合症的中药组合物及其应用 - Google Patents
一种治疗疲劳综合症的中药组合物及其应用 Download PDFInfo
- Publication number
- CN105456699A CN105456699A CN201510894366.2A CN201510894366A CN105456699A CN 105456699 A CN105456699 A CN 105456699A CN 201510894366 A CN201510894366 A CN 201510894366A CN 105456699 A CN105456699 A CN 105456699A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- parts
- traditional chinese
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 13
- 210000003734 kidney Anatomy 0.000 claims abstract description 23
- 210000004185 liver Anatomy 0.000 claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 239000008280 blood Substances 0.000 claims abstract description 12
- 210000004369 blood Anatomy 0.000 claims abstract description 12
- 241001122767 Theaceae Species 0.000 claims description 16
- 206010003549 asthenia Diseases 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 2
- 230000006870 function Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 208000009205 Tinnitus Diseases 0.000 abstract description 5
- 208000002173 dizziness Diseases 0.000 abstract description 5
- 231100000886 tinnitus Toxicity 0.000 abstract description 5
- 230000007812 deficiency Effects 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 2
- 206010021118 Hypotonia Diseases 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 208000017561 flaccidity Diseases 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 description 13
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 8
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017472 Fumbling Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- -1 compound vitamin Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000011850 initial investigation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗疲劳综合症的中药组合物(固本茶),所述的中药组合物由以下原料制成:枸杞子、炒黑芝麻、山茱萸、黄精6份。本发明还提供该中药组合物的应用。其优点表现在:本发明的中药组合物中诸药合用,共奏补益肝肾、养血益精之功。功能主治:功能补益肝肾,养血益精。主治肝肾精血亏虚之证,证见腰酸、脚软、眩晕、耳鸣、舌红少津、脉沉细等。
Description
技术领域
本发明涉及保健茶技术领域,具体地说,是一种治疗疲劳综合症的中药组合物(固本茶)及其应用。
背景技术
慢性疲劳综合征(Chronicfatiguesyndrome,CFS)是一种以慢性疲劳为突出表现,同时伴有低热、淋巴结肿痛、肌肉酸痛、关节疼痛、神经精神症状、免疫学异常和其它非特异表现的综合征。体检和常规实验室检查一般无异常发现,由美国疾病控制中心于1988年正式命名。1994年,美国疾病控制中心在其研究大纲中将自我报告的持续或反复发作6个月或更长时间的疲劳定义为“慢性疲劳”。
疲劳综合症很常见,据中国健康教育协会在深圳、上海、北京、广州等10大城市组织的慢性疲劳综合症初步调查结果显示,各城市人群慢性疲劳综合症发病率在10%-25%之间,白领是慢性疲劳综合症的“高危人群”,经常感到疲惫不堪,是典型的“亚健康状态”。
目前临床上尚无治疗慢性疲劳综合症的有效药物,西医使用的抗病毒、抗抑郁、补充维生素及免疫调节剂、认知心理疗法等治疗处于摸索阶段。因此,人们把目光转向传统医学领域,科技论文和专利文献中有不少报道,例如,中国专利文献CN03109331.0公开了一种抗疲劳药物:西洋参5-15份、决明子10-20份、枸杞子5-15份、黄芪5-15份、制首乌1-10份、山楂5-15份。中国专利文献CN104688855A公开了一种治疗慢性疲劳综合症的中药:黄连、阿胶、白芍、黄芩、酸枣仁、肉桂和合欢皮。但是关于本发明的一种治疗疲劳综合症的中药组合物(固本茶)及其应用目前还未见报道。
发明内容
本发明的目的是针对现有技术中的不足,提供一种治疗疲劳综合症的中药组合物。
本发明的再一的目的是,提供一种治疗疲劳综合症的中药组合物的应用。
为实现上述目的,本发明采取的技术方案是:一种治疗疲劳综合症的中药组合物,所述的中药组合物由以下重量份的原料药制成:枸杞子6-12份,炒黑芝麻4-8份,山茱萸2-4份,黄精4-8份。
所述的中药组合物由以下重量份的原料药制成:枸杞子8-10份,炒黑芝麻5-7份,山茱萸2.5-3.5份,黄精5-7份。
所述的中药组合物由以下重量份的原料药制成:枸杞子9份,炒黑芝麻6份,山茱萸3份,黄精6份。
为实现上述第二个目的,本发明采取的技术方案是:所述的中药组合物在制备抗疲劳的药物、食品、保健品中的应用。
所述的中药组合物在制备治疗肝肾精血亏虚之证的药物、食品、保健品中的应用。
所述的固本袋泡茶由以下重量份的原料药清洗干净、干燥后,粉碎,灭菌后用袋泡茶包装机将粉末分装入滤纸袋:枸杞子6-12份,炒黑芝麻4-8份,山茱萸2-4份,黄精4-8份。
本发明优点在于:
1、本发明的中药组合物(固本茶)的功能主治:功能补益肝肾,养血益精。主治肝肾精血亏虚之证,证见腰酸、脚软、眩晕、耳鸣、舌红少津、脉沉细等。
2、本发明的中药组合物(固本茶)的方解:枸杞子,味甘性平,归肝肾肺经。功能养肝,滋肾。《药性论》言其“能补益精诸不足,易颜色,变白,明目,安神,令人长寿。”《本草纲目》言其“滋肾,润肺,明目。”《食疗本草》言其“坚筋耐老,除风,补益筋骨,能益人,去虚劳。”本方用枸杞子平补肝肾精血,为方中君药。黑芝麻,味甘性平,归肝脾肾经。功能补益肝肾,养血益精,润肠通便。《本经》言其“主伤中,虚羸,补五内,益气力,长肌肉,填脑髓。久服轻身不老。”可增强君药滋补肝肾之力,为方中臣药。山茱萸,味酸,性微温,归肝肾经。功能补益肝肾,收敛固脱;黄精,味甘性平,归脾肺肾经。功能养阴润肺,补脾益气,滋肾填精,二者共为方中佐药。诸药合用,共奏补益肝肾、养血益精之功。
3、病因病机及治法:肝肾精血亏虚之证,多因久病失调,阴液亏虚;或因情志内伤,化火伤阴;或因房事不节,耗伤肾阴;或因温热病久,津液被劫所致。肝肾阴亏,不能上养清窍,下养腰膝,故见耳鸣、腰膝酸软;水不涵木,肝阳上扰,则见眩晕。治疗上宜以补益肝肾、养血益精为法。
具体实施方式
下面结合实施例对本发明提供的具体实施方式作详细说明。
一种治疗疲劳综合症的中药组合物(固本茶),所述的中药组合物由以下重量份的原料药制成:枸杞子6-12份,炒黑芝麻4-8份,山茱萸2-4份,黄精4-8份。优选地,枸杞子8-10份,炒黑芝麻5-7份,山茱萸2.5-3.5份,黄精5-7份。
实施例1
枸杞子9份,炒黑芝麻6份,山茱萸3份,黄精6份。
实施例2
枸杞子8份,炒黑芝麻5份,山茱萸3.5份,黄精7份。
实施例3
枸杞子10份,炒黑芝麻7份,山茱萸2.5份,黄精5份。
实施例4
枸杞子6份,炒黑芝麻8份,山茱萸2份,黄精4份。
实施例5
枸杞子12份,炒黑芝麻4份,山茱萸4份,黄精8份。
实施例6
实施例1-5任一所述的中药组合物使用开水冲泡,15分钟后饮用。
实施例7
实施例1-5任一所述的中药组合物,清洗干净、干燥后,粉碎,灭菌后用袋泡茶包装机将粉末分装入滤纸袋。
实施例1的中药组合物,清洗干净,干燥,粉碎成1mm-2mm的粉末,高压蒸汽灭菌柜灭菌15min-30min,取出,放冷,用袋泡茶包装机将粉末分装入滤纸袋,每袋10g,封口。
实施例8
实施例1-5任一所述的中药组合物,加水煎煮提取,过滤合并滤液,将滤液浓缩成浸膏,加入药用辅料制成颗粒剂、胶囊剂、口服液、片剂等。
实施例9
急性毒性实验
取小鼠40只,体重19-22g,雌雄各半,随机分2组:第一组16g/kg、第二组20g/kg。将本实施例1的中药组合物按煎煮法制得汤剂,灌胃给药,给药前禁食6小时,给药后观察14天。
实验结果:给药后小鼠处于安静状态,1小时后恢复原来状态,饮食、活动及大小便正常,观察14天后无一只小鼠死亡。
结论:本品是安全的。
实施例10
取小鼠40只,体重20-22g,雌雄各半,随机分4组:空白对照组(蒸馏水)及3个治疗组(实施例1的中药组合物3.0、2.0、1.0g/kg,煎煮法制成汤剂)。按0.2ml/10g体重灌胃给药,每天给药1次,连续给药7天。末次给药后1小时,按0.510g/g体重在尾部负重物,放入装有水的(50cm×30cm×25cm)缸内游泳,水温为20±0.5℃,记录每组小鼠游泳时间。实验结果见下表:
实施例11
从临床选取50例慢性疲劳综合症患者,随机分为2组,对照组服用复合维生素金维他,按药品说明书规定服用;治疗组服用本发明实施例1的中药组合物,每日上午9点和下午3点各服用1袋该茶(实施例1),即取1袋该茶用250ml的开水冲泡,15分钟后饮用,每袋茶可冲泡3次。服用30天后,经3000米慢跑试验和自我感觉,其疗效结果如下表所示:
实施例12
200例患者均被诊断为疲劳综合症,中医辨证为肝肾亏虚型,患者主要表现为腰酸、脚软、眩晕、耳鸣、舌红少津、脉沉细等,所有患者经腹部B超及肝肾功能等相关检查,排除有明显器质性病变者。所有患者均取自上海长海医院中医门诊和东海舰队某单位门诊病人,时间集中在2014年1月~2015年7月,其中男125例,女75例,年龄在18-60岁,病程最短1周,最长10年。
所有患者每日上午9点和下午3点各服用1袋该茶(实施例1),即取1袋该茶用250ml的开水冲泡,15分钟后饮用,每袋茶可冲泡3次。
结果发现大部分患者1周后腰酸、脚软、眩晕、耳鸣、舌红少津、脉沉细等症状得到明显改善,2周后上述症状基本消失,治愈108例,占54%,显效44例占22%,有效30例,占15%,无效18例,占9%,总有效率为91%。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员,在不脱离本发明方法的前提下,还可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。
Claims (6)
1.一种治疗疲劳综合症的中药组合物,其特征在于,所述的中药组合物由以下重量份的原料药制成:枸杞子6-12份,炒黑芝麻4-8份,山茱萸2-4份,黄精4-8份。
2.根据权利要求1所述的中药组合物,其特征在于,所述的中药组合物由以下重量份的原料药制成:枸杞子8-10份,炒黑芝麻5-7份,山茱萸2.5-3.5份,黄精5-7份。
3.根据权利要求1所述的中药组合物,其特征在于,所述的中药组合物由以下重量份的原料药制成:枸杞子9份,炒黑芝麻6份,山茱萸3份,黄精6份。
4.根据权利要求1-3任一所述的中药组合物在制备抗疲劳的药物、食品、保健品中的应用。
5.根据权利要求1-3任一所述的中药组合物在制备治疗肝肾精血亏虚之证的药物、食品、保健品中的应用。
6.一种固本袋泡茶,其特征在于,所述的固本袋泡茶由以下重量份的原料药清洗干净、干燥后,粉碎,灭菌后用袋泡茶包装机将粉末分装入滤纸袋:枸杞子6-12份,炒黑芝麻4-8份,山茱萸2-4份,黄精4-8份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510894366.2A CN105456699A (zh) | 2015-12-07 | 2015-12-07 | 一种治疗疲劳综合症的中药组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510894366.2A CN105456699A (zh) | 2015-12-07 | 2015-12-07 | 一种治疗疲劳综合症的中药组合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105456699A true CN105456699A (zh) | 2016-04-06 |
Family
ID=55595155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510894366.2A Pending CN105456699A (zh) | 2015-12-07 | 2015-12-07 | 一种治疗疲劳综合症的中药组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105456699A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108142946A (zh) * | 2017-11-28 | 2018-06-12 | 宁夏夏瑞生物科技有限公司 | 一种甘草养生胶囊及其制备方法和用途 |
-
2015
- 2015-12-07 CN CN201510894366.2A patent/CN105456699A/zh active Pending
Non-Patent Citations (4)
Title |
---|
徐勇刚: "《肾虚的男人老得快》", 31 March 2015, 浙江科学技术出版社 * |
范运祥: "《田径竞赛裁判学》", 31 August 2015, 湘潭大学出版社 * |
谢海洲: "《谢海洲临床经验辑要》", 28 February 2001, 中国医药科技出版社 * |
陈家旭: "《疲劳综合征调养与护理》", 31 May 1999, 中国中医药出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108142946A (zh) * | 2017-11-28 | 2018-06-12 | 宁夏夏瑞生物科技有限公司 | 一种甘草养生胶囊及其制备方法和用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101502625B (zh) | 治疗妇女产后综合症的中药及其制备方法 | |
CN103041209A (zh) | 一种治疗肾阴虚的中药制剂及其制备方法 | |
CN104013756B (zh) | 一种防治腹泻的中药组合物及其用途 | |
CN104189789A (zh) | 一种治疗急性传染性黄疸型肝炎的中药组合物 | |
CN102133271A (zh) | 一种治疗痛风病的药茶 | |
CN102940785B (zh) | 一种治疗眩晕症的中药组合物 | |
CN103550687B (zh) | 一种治疗肝肾阴虚的中药组合物 | |
CN101095768B (zh) | 一种治疗中老年原发性高血压的中药胶囊 | |
CN104043050A (zh) | 一种治疗胆囊炎的中药组合物 | |
CN104189811A (zh) | 一种治疗产后血晕的中药组合物及其制备方法 | |
CN103341127A (zh) | 一种配合血液透析治疗尿毒症的中药及制备方法 | |
CN101199796B (zh) | 一种外用止泻药物及其制备方法和用途 | |
CN105079551A (zh) | 一种治疗水肿的中药组合物 | |
CN103735788A (zh) | 一种治疗水肿的中药组合物 | |
CN103330837B (zh) | 一种治疗绝经妇女骨质疏松症的中药组合物 | |
CN104857188A (zh) | 一种治疗水肿的中药组合物 | |
CN105250954B (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN105456699A (zh) | 一种治疗疲劳综合症的中药组合物及其应用 | |
CN103041233A (zh) | 一种治疗小儿腹泻的药物组合物及其制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN103751489B (zh) | 一种治疗神经外科术后疼痛药物的制备方法 | |
CN103751488B (zh) | 一种治疗神经外科手术后高敏状态的药物 | |
CN102764411A (zh) | 一种治疗黄疸的药物组合物及其制备方法 | |
CN103816327B (zh) | 一种治疗肠梗阻的中药组合物及其制备方法 | |
CN103656199B (zh) | 一种治疗肾阴不足证型咳嗽的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160406 |
|
RJ01 | Rejection of invention patent application after publication |